Navigation Links
Evista in Medical News

Lilly Reports Solid Second-Quarter 2009 Results, Raises EPS Guidance

... 275.0 40% 720.6 522.1 38% evista 251.3 279.8 (10)% 508.2 ...rable impact of foreign exchange rates. evista evista sales were $251.3 million in the second quarter of...

Drug May Extend Life When Breast Cancer Spreads

...delines from the American Society of Clinical Oncology stating that women at a heightened risk of developing breast cancer might benefit from the drug evista (raloxifene) in addition to tamoxifen. Previous guidelines recommended only tamoxifen. More information The U.S. National Cancer Institute h...

Lilly Granted Preliminary Injunction to Prevent Launch of Generic Raloxifene

...ntinues to Defend Intellectual Property Rights for evista INDIANAPOLIS, April 22 /PRNewswire-FirstCall/...ring that the intellectual property protection for evista remains in place until the Court renders its final...or Lilly. "We believe Teva's challenges to Lilly's evista patents are without merit and we expect to prevail...

Lilly Reports Strong First-Quarter 2009 Results

...ently prohibits the launch of a generic version of evista by Teva Pharmaceuticals. The company expects a rul... 335.3 247.2 36% evista 256.9 261.1 (2...favorable impact of foreign exchange rates. evista ...

Lilly Granted Temporary Restraining Order to Halt Launch of Generic Raloxifene

...or Lilly. "We believe Teva's challenges to Lilly's evista patent are without merit and we expect to prevail ... our patents against those who violate them." evista is a breakthrough medicine indicated for the treat... Teva Pharmaceuticals Industries Ltd. About evista EVISTA(R), a selective estrogen receptor modulat...

Lilly Reports Fourth-Quarter and Full-Year 2008 Results

... 244.1 31% 1,154.7 854.0 35% evista 269.0 285.8 (6)% 1,075.6 ...avorable impact of foreign exchange rates. evista evista sales were $269.0 million in the fourth quarter of...

Lilly Caps Successful Year with Strong Fourth-Quarter Results

... sales are reported in Lilly's revenue. Evista evista sales were $285.8 million in the fourth quarter, a...wer demand. For the full year of 2007, worldwide evista sales increased 4 percent, to $1.091 billion. U.S. evista sales for 2007 were $706.1 million, a 6 percent in...

Lilly Showcases Pipeline Opportunities to Wall Street, Sets 2008 Financial Guidance and Outlines Transformation Strategy

...r review in the U.S. and European Union for a new indication for glucocorticoid induced osteoporosis, or GIOP. Evista(R) The FDA recently approved evista for a new use to reduce the risk of invasive breast cancer in two populations: postmenopausal women with osteoporosis and postmenopausal women at high...

Lilly Delivers Strong Third-Quarter Results

...er, the U.S. Food and Drug Administration approved evista for a new use to reduce the risk of invasive b...change rates, offset in part by declining prices. evista evista sales were $263.2 million in the third quarter, a ...

FDA Approves Osteoporosis Drug to Cut Breast Cancer Risk

... Manufacturer calls evista a valuable tool, but critics say its heart risks o...and Company said Friday that its osteoporosis drug evista has received U.S. approval for use in preventing b... Committee voted 8 to 6 to recommended approval of evista (raloxifene) for postmenopausal women with osteopo...
Evista in Medical Technology

FDA Approves Lilly's Osteoporosis Drug EVISTA(R) (raloxifene HCl) to Reduce The Risk of Invasive Breast Cancer in Two Populations of Postmenopausal Women

...rs. Earlier this year, the osteoporosis label for evista was updated to include safety information from the... history of venous thromboembolism should not take evista and that women at risk for stroke should receive evista only after evaluating the risk-benefit balance wit...
Evista in Biological Technology

Halozyme Therapeutics Appoints Head of Endocrinology Clinical Development

...nsulin program and its recombinant human hyaluronidase enzyme technology. Prior to leading Lilly's inhaled insulin program, Dr. Muchmore served on the evista Product Team for osteoporosis and breast cancer indications from 1995 to 1999 and as its Physician Group Leader from 1997 to 1999. He is the recipient...

Lilly Reports Solid Second-Quarter Results

...ide the U.S. increased 28 percent, to $233.8 million, driven primarily by higher demand and the favorable impact of foreign exchange rates. Evista evista sales were $279.8 million in the second quarter of 2008, a 1 percent increase compared with the second quarter of 2007. U.S. sales of Evista increased...

CBI and PharmaVoice Announce Recipients of the Strategic Patient Adherence Awards

...d Robert Nauman, BioPharma Advisors and a judge for the SPA awards. Rx Canada and their client (Eli Lilly Canada) received an innovation award for the evista Inner Strength Program which ensured that pharmacists followed up with patients 2 weeks after their first intervention. Finally, AstraZeneca received ...

Lilly Reports Solid First-Quarter Results

...es, net of expenses, was reported in Lilly's other income. After the acquisition of ICOS, all Cialis sales are reported in Lilly's revenue. Evista evista sales were $261.1 million in the first quarter of 2008, a 1 percent decrease compared with the first quarter of 2007. U.S. sales of Evista were essent...
Other Tags
(Date:12/24/2014)... (PRWEB) December 24, 2014 Connie Casad, ... and functional medicine advocate with 30 years of practice ... to evaluate the health benefits of dietary detoxification. The ... new participants following excellent results from test patients who ... asked to explain her interest in conducting the study, ...
(Date:12/24/2014)... Risperdal lawsuit ( http://www.risperdallawsuit2014.com/ ) ... currently underway in Pennsylvania’s Philadelphia Court of Common Pleas, ... 2014, court documents indicate that 1,183 claims had been ... developed gynecomastia (male breast growth) and other complications allegedly ... that this represents an increase of more than 100 ...
(Date:12/24/2014)... Dr. Vu Ho, a Dallas based facial plastic ... med-spa with the addition of new Silk Peel skin ... and services. , “Silk Peel is a procedure that ... “As a result it can address issues like acne ... or blemishes.” , Similar to microdermabrasion, Silk Peel ...
(Date:12/24/2014)... 25, 2014 Today, UWDress.com, the famous women’s ... wedding gowns, and launched a site-wide wedding gown promotion. ... wedding gowns in a more unexpected way, the collection should ... popular in the global market, and they are available with ... are offered at discounted prices, up to 75% off; most ...
(Date:12/24/2014)... (PRWEB) December 25, 2014 The report ... 2023” focuses on the current treatment landscape, unmet needs, ... market. Stivarga is a drug which is used in ... is orally administered and is also prescribed to patients ... which is FDA approved is a multi-kinase inhibitor and ...
Breaking Medicine News(10 mins):Health News:Connie Casad, MD, Now Accepting Test Participants for January Dietary Detoxification Study 2Health News:Connie Casad, MD, Now Accepting Test Participants for January Dietary Detoxification Study 3Health News:Risperdal Lawsuits Continue to Climb, as Claims in Pennsylvania Litigation Exceed 1,180 Filings, Bernstein Liebhard LLP Reports 2Health News:Risperdal Lawsuits Continue to Climb, as Claims in Pennsylvania Litigation Exceed 1,180 Filings, Bernstein Liebhard LLP Reports 3Health News:Risperdal Lawsuits Continue to Climb, as Claims in Pennsylvania Litigation Exceed 1,180 Filings, Bernstein Liebhard LLP Reports 4Health News:Dr. Vu Ho Expands Facial Plastic Surgery Practice to Include New Skin Care Treatment 2Health News:Buy Cheap Long Sleeve Wedding Gowns At UWDress.com 2Health News:Stivarga Colorectal Cancer Treatment Market Analysis and Forecast to 2023 Report at RnRMarketReserach.com 2Health News:Stivarga Colorectal Cancer Treatment Market Analysis and Forecast to 2023 Report at RnRMarketReserach.com 3
(Date:12/11/2014)... 10, 2014  Data Sciences International (DSI), the ... a new series of digital telemetry implants to ... M series, part of the PhysioTel™ Digital platform, ... possible physiologic data when incorporating functional endpoints into ... to toxicology studies has evolved from short ECG ...
(Date:12/10/2014)... DIEGO , Dec. 9, 2014 CIE ... collaboration catalyst that provides the connective tissue that enhances ... enabling them to easily share client-level information; earned a ... to expand to organizations serving seniors aging in community ... Diego" partner on December 11 th 4-6p. ...
(Date:12/5/2014)... , Dec. 4, 2014  Tute Genomics, a ... $2.3 million in Series A1 funding led by UK-based ... also participated in the investment round. "We ... healthcare community adopts next-generation sequencing and seeks new approaches ... Reid Robison , MD MBA, and CEO of ...
Breaking Biology News(10 mins):New telemetry implants expected to change how large animal toxicology studies are conducted 2Community Information Exchange San Diego Launches Pilot, Secures $1 Million Expansion Grant, and Becomes a "Live Well San Diego" Partner 2Community Information Exchange San Diego Launches Pilot, Secures $1 Million Expansion Grant, and Becomes a "Live Well San Diego" Partner 3Community Information Exchange San Diego Launches Pilot, Secures $1 Million Expansion Grant, and Becomes a "Live Well San Diego" Partner 4Tute Genomics Raises $2.3 Million to Scale Up Cloud-Based Genome Analytics and Accelerate Personalized Medicine 2Tute Genomics Raises $2.3 Million to Scale Up Cloud-Based Genome Analytics and Accelerate Personalized Medicine 3
Other Contents